BBNX Stock Analysis: Buy, Sell, or Hold?
BBNX - Beta Bionics, Inc. Common Stock
$14.38
-0.15 (-1.03%)
▼
5d:
+3.68%
30d:
+56.3%
90d:
+32.29%
HOLD
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When BBNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: BBNX is 7.7% above its trading range ($13.35). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: BBNX is 7.7% above its trading range ($13.35). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: BBNX is currently trading at $14.38, which is considered extended relative to its 30-day fair value range of $9.75 to $13.35.
Technical Outlook: Technically, BBNX is in a downtrend. Immediate support is located at $12.26, while resistance sits at $15.00.
Market Sentiment: BBNX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.18 (+33.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BBNX is in a downtrend. Immediate support is located at $12.26, while resistance sits at $15.00.
Market Sentiment: BBNX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.18 (+33.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.75 -
$13.35
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+7.7% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 33.4% below Wall St target ($19.18)
Trading Range Analysis
30-Day Trading Range
$9.75 -
$13.35
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$12.26
Resistance Level
$15.00
Current Trend
Downtrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.02
Wall Street Target
$19.18
(+33.4%)
Revenue Growth (YoY)
56.6%
Profit Margin
-60.3%
Share & Embed Analysis
Last updated: June 16, 2026 12:08 AM ET
Data refreshes hourly during market hours. Next update: 1:08 AM
Data refreshes hourly during market hours. Next update: 1:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark Hopman
SELL
353 shares
2026-03-04
Mark Hopman
SELL
834 shares
2026-03-02
Mike Mensinger
SELL
1064 shares
2026-03-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 60 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 53 HOLD |
